Pfizer UK Continuity in Care Call for Patients with Cancer During COVID-19 Pandemic

Pfizer UK Continuity in Care Call for Patients with Cancer During COVID-19 Pandemic

Tuesday, 08 September, 2020

Pfizer Global Medical Grants (GMG) support the global healthcare community’s independent initiatives (research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. A GMG Independent Medical Education Grant is a type of grant which consists of Pfizer funding for independent medical education activities or initiatives which serve to maintain, develop, or increase the knowledge, skills, and/or professional performance of a healthcare professional (continuing medical education, continuing health education, continuing education).

In certain clinical areas, specific Requests for Proposals (RFPs) will be posted.

The aim of the '2020 Oncology UK: Continuity in Care for Patients with Cancer During COVID-19 Pandemic' RFP is to provide funding for initiatives that support the educational needs of healthcare professionals (HCPs) and patients regarding the management of cancer patients during the COVID-19 pandemic.

Educational programmes to help HCPs meet the rapidly evolving needs of cancer patients during this challenging time will be supported. Programmes should be focused on one or more of the following:

  • Development of online educational content for cancer patients.
  • Multi-disciplinary simulation education around effective tele/video services.
  • Educational content on effective virtual multi-disciplinary meetings.
  • Topics around how to train junior doctors in oncology and haemato-oncology in a virtual world.
  • Education on the effective utilisation of tools designed to facilitate remote interaction between cancer patients and HCPs.

Eligible applicants are healthcare organisations, academic organisations, patient organisations, charities and other organisations with an interest in improving outcomes for patients with cancer.

If the project involves multiple departments within an institution and/or between different institutions/organisations/associations, all institutions must have a relevant role and the requesting organisation must have a key role in the project.

The geographic scope of this RFP is UK only.

The estimated total available budget related to this RFP is £150,000. Individual projects requesting up to a maximum of £50,000 will be
considered (the expected range of grant requests under this RFP is approximately £5,000 to £50,000).

Applications should be submitted by the deadline of 6 October 2020.

More information about this research funding opportunity and the application process is available on the RESEARCHconnect funding information platform. RESEARCHconnect provides up-to-the minute content, insight and analysis on research funding news and policy. To find out more about how RESEARCHconnect can keep you in the know, and subscription fees, contact us today.

 

other funding news

Our experienced content team is skilled at sourcing funding opportunities, reporting on the latest hot topics and providing accurate, comprehensive funding content which supports organisations and their beneficiaries in their quest for funding.

Interested in finding out more about
RESEARCHconnect and subscription fees?

RESEARCHconnect

Supporting you at every step of your funding journey